Page last updated: 2024-08-24

fadrozole and Carcinoma

fadrozole has been researched along with Carcinoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Jong, PC; Dingemans, M; Heneweer, M; Muusse, M; Sanderson, JT; van den Berg, M1
Bria, E; Carlini, P; Cognetti, F; Di Cosimo, S; Fabi, A; Felici, A; Ferretti, G; Giannarelli, D; Milella, M; Mottolese, M; Nisticò, C; Papaldo, P; Ruggeri, EM; Terzoli, E1
Bonomi, P; Buzdar, AU; Cooper, J; Favis, G; Keller, AM; Mulagha, M; Smith, R; Vogel, C1
Demers, L; Grossberg, H; Leitzel, K; Lipton, A; Teramoto, Y; Volas, GH1

Reviews

1 review(s) available for fadrozole and Carcinoma

ArticleYear
New aromatase inhibitors as second-line endocrine therapy in postmenopausal patients with metastatic breast carcinoma: a pooled analysis of the randomized trials.
    Cancer, 2005, Oct-01, Volume: 104, Issue:7

    Topics: Aged; Anastrozole; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Clinical Trials, Phase III as Topic; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Fadrozole; Female; Humans; Letrozole; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Probability; Prognosis; Remission Induction; Risk Assessment; Survival Analysis; Triazoles

2005

Trials

2 trial(s) available for fadrozole and Carcinoma

ArticleYear
Fadrozole HCL (CGS-16949A) versus megestrol acetate treatment of postmenopausal patients with metastatic breast carcinoma: results of two randomized double blind controlled multiinstitutional trials.
    Cancer, 1996, Jun-15, Volume: 77, Issue:12

    Topics: Adult; Aged; Breast Neoplasms; Carcinoma; Double-Blind Method; Fadrozole; Female; Humans; Megestrol; Menopause; Middle Aged; Prognosis; Prospective Studies; Survival Analysis

1996
Serial serum c-erbB-2 levels in patients with breast carcinoma.
    Cancer, 1996, Jul-15, Volume: 78, Issue:2

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Disease Progression; Double-Blind Method; Enzyme Inhibitors; Fadrozole; Female; Humans; Megestrol; Megestrol Acetate; Placebos; Prognosis; Receptor, ErbB-2; Remission Induction; Treatment Outcome

1996

Other Studies

1 other study(ies) available for fadrozole and Carcinoma

ArticleYear
Co-culture of primary human mammary fibroblasts and MCF-7 cells as an in vitro breast cancer model.
    Toxicological sciences : an official journal of the Society of Toxicology, 2005, Volume: 83, Issue:2

    Topics: Aromatase; Aromatase Inhibitors; Benzhydryl Compounds; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Coculture Techniques; Dexamethasone; Diethylstilbestrol; Drug Synergism; Estradiol; Fadrozole; Female; Fibroblasts; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Mammary Glands, Human; Phenols; Prostaglandin-Endoperoxide Synthases; Proteins; RNA, Messenger; Transcription, Genetic; Trefoil Factor-1; Tumor Suppressor Proteins

2005